Traduction de «–947 41 –252 » (Français → Néerlandais) :

Produits financiers 384 531 –28 58 245 –76 Charges d’intérêts –290 –237 22 –76 –61 25 Impôts –1 336 –947 41 –252 –254 –1 Résultat opérationnel, activités poursuivies 1 8 163 6 540 25 1 507 931 62
Income from associated companies 441 412 7 97 104 –7 Financial income 384 531 –28 58 245 –76 Interest expense –290 –237 22 –76 –61 25 Taxes –1 336 –947 41 –252 –254 –1 Net income from continuing operations 1 8 163 6 540 25 1 507 931 62

M01AA DERIVES DE LA PYRAZOLONE 141.847 133.357 121.816 108.140 104.884 103.494 27.430 M01AB DERIVES DE L'ACIDE ACETIQUE ET SUBSTANCES APPARENTE 37.985.872 39.784.736 39.772.921 39.837.535 41.137.476 42.791.801 54.502.210 55.059.768 54.947.511 M01AC OXICAMES 41.177.610 42.266.269 41.471.131 39.944.203 39.131.448 37.371.904 38.683.136 36.252.073 35.429.930 M01AE DERIVES DE L'ACIDE PROPIONIQUE 39.586.983 40.157.913 40.244.008 41.119.607 41.897.105 44.036.930 50.992.108 52.258.006 53.002.148 M01AH COXIBS 14.984.792 16.930.491 20.380.585 8.106.766 28 2.220.501 3.436.321 3.713.548 3.843.850 M01AX AUTRES ANTI-INFLAMMATOIRES/ANTIRHUMASTISMAUX NON ST 10.740.877 10.019.604 10.331.478 10.963.726 11.369.225 10.502.013 1.600.719 3.729.496 4.665.286 Total 144.617.981 149.292.371 152.321.938 140.079.978 133.640.166 137.026.644 149.241.925 151.012.890 151.888.725
M01AA PYRAZOLINONDERIVATEN 141.847 133.357 121.816 108.140 104.884 103.494 27.430 M01AB AZIJNZUURDERIVATEN EN VERWANTE STOFFEN 37.985.872 39.784.736 39.772.921 39.837.535 41.137.476 42.791.801 54.502.210 55.059.768 54.947.511 M01AC OXICAMDERIVATEN 41.177.610 42.266.269 41.471.131 39.944.203 39.131.448 37.371.904 38.683.136 36.252.073 35.429.930 M01AE PROPIONZUURDERIVATEN 39.586.983 40.157.913 40.244.008 41.119.607 41.897.105 44.036.930 50.992.108 52.258.006 53.002.148 M01AH COXIBS 14.984.792 16.930.491 20.380.585 8.106.766 28 2.220.501 3.436.321 3.713.548 3.843.850 M01AX OVERIGE NIET-STEROIDE ANTIINFLAMMATOIRE/ANTIRHEUMATISCHE MIDDELEN 10.740.877 10.019.604 10.331.478 10.963.726 11.369.225 10.502.013 1.600.719 3.729.496 4.665.286 Totaal 144.617.981 149.292.371 152.321.938 140.079.978 133.640.166 137.026.644 149.241.925 151.012.890 151.888.725

A ACTION INTERMEDIAIRE AVEC DEBUT D'ACTION RAPIDE 0,9% 130.282 3.167 0,7% 36 40 31 34 A10AB INSULINES ET ANALOGUES A ACTION RAPIDE 0,9% 126.702 2.985 0,7% 39 41 32 30 G03AB PROGESTATIFS ET ESTROGENES, ASSOCIATIONS SEQUENTIELLES 0,9% 123.564 15.781 3,5% 4 4 33 42 M05BA BIPHOSPHONATES 0,9% 121.943 1.546 0,3% 63 79 34 36 A07EC MESALAZINE ET SIMILAIRES 0,8% 117.947 2.593 0,6% 45 45 35 44 R03AC BETA 2 SYMPATHOMIMETIQUES SELECTIFS 0,8% 117.447 5.664 1,2% 18 16 36 35 G03DA DERIVES DU PREGNENE(4) 0,8% 116.610 5.785 1,3% 17 18 37 32 J01DA CEPHALOSPORINES ET APPARENTES 0,8% 116.120 1.065 0,2% 82 102 38 31 J01FA MACROLIDES 0,8% 114.629 905 0,2% 86 86 39 39 M01AB DERIVES DE L'ACIDE ACETIQUE ET SUBSTANCES APPARENTEES 0,8% 114.341 4.563 1,0% 24 26 40 37 G03CA ESTROGENES NATURELS ET SEMISYNTHETIQUES, MONOCOMPOSES 0,8% 107.628 19.961 4,4% 3 3 41 40 R01AD CORTICOSTEROIDES 0,8% 107.097 6.228 1,4% 14 13 42 38 M01AE DERIVES DE L'ACIDE PROPIONIQUE 0,7% 102.429 5.518 1,2% 19 15 43 43 C01DX AUTRES VASODILATATEURS POUR MALADIES CARDIAQUES 0,7% 101.293 5.209 1,1% 20 24 44 49 N02AX AUTRES OPIACES 0,7% 99.410 1.281 0,3% 72 76 45 45 B02BD FACTEURS DE COAGULATION 0,7% 96.233 7 0,0% 261 259 46 47 A10AC INSULINES ET ANALOGUES A ACTION INTERMEDIAIRE 0,7% 91.881 2.242 0,5% 50 50 47 46 R06AE DERIVES DE LA PIPERAZINE 0,6% 88.899 3.713 0,8% 29 30 48 64 L02BB ANTI-ANDROGENES 0,6% 88.633 423 0,1% 125 134 49 50 G03FB PROGESTATIFS ET ESTROGENES, ASSOCIATIONS SEQUENTIELLES 0,6% 86.690 11.226 2,5% 6 6 50 56 L03AA FACTEURS DE CROISSANCE DES COLONIES 0,6% 82.267 17 0,0% 235 229 51 51 D01BA ANTIMYCOSIQUES A USAGE SYSTEMIQUE 0,6% 81.195 874 0,2% 90 88 52 54 R06AX AUTRES ANTIHISTAMINIQUES A USAGE SYSTEMIQUE 0,6% 79.992 3.351 0,7% 35 36 53 58 R05CB MUCOLYTIQUES 0,6% 79.243 862 0,2% 92 104 54 48 N06AA INHIBITEURS NON SELECTIFS DU RECAPTAGE DE MONOAMINE 0,6% 78.712 4.628 1,0% 23 20 55 41 J07BC VACCINS DE L'HEPATITE 0,5% 74.471 118 0,0% 174 157 56 52 G03DB DERIVES DU PREGNADIENE 0,5% 72.695 4.745 1,0% 21 19 57 62 J0 ...
VAN HET REVERSE TRANSCRIPTASE 0,5% 72.675 76 0,0% 187 191 58 55 J01CA PENICILLINES MET BREED SPECTRUM 0,5% 70.903 950 0,2% 85 82 59 * N05AH DIAZEPINEN, OXAZEPINEN EN THIAZEPINEN 0,5% 68.785 370 0,1% 127 * 60 60 H05BA CALCITONINE 0,5% 68.738 343 0,1% 129 130 61 53 C10AB FIBRATEN 0,5% 68.418 3.641 0,8% 30 35 62 59 S01CA CORTICOSTEROIDEN MET ANTIMICROBIELE MIDDELEN 0,5% 66.702 3.037 0,7% 38 37 63 61 B01AC TROMBOCYTENAGGREGATIEREMMERS, HEPARINE UITGEZONDERD 0,5% 66.629 1.941 0,4% 55 53 64 57 A02BA H2-RECEPTORBLOKKERENDE MIDDELEN 0,4% 62.419 991 0,2% 83 72 65 77 N03AX OVERIGE ANTI-EPILEPTICA 0,4% 61.135 437 0,1% 123 126 66 67 H01CB ANTIGROEIHORMOON 0,4% 60.055 58 0,0% 196 197 67 66 A10BB SULFONYLUREUMDERIVATEN 0,4% 58.068 3.110 0,7% 37 38 68 74 N04BC DOPAMINE-AGONISTEN 0,4% 57.774 313 0,1% 134 136 69 90 C09CA ANTAGONISTEN VAN HET ANGIOTENSINE II, ENKELVOUDIG 0,4% 57.653 1.406 0,3% 66 103 70 69 S01BC NIET-STEROIDALE ANTI-INFLAMMATOIRE MIDDELEN 0,4% 56.008 1.678 0,4% 61 60 71 68 D07AC STERK WERKZAME CORTICOSTEROIDEN (GROEP III) 0,4% 55.954 1.310 0,3% 71 66 72 63 N05AD BUTYROFENONDERIVATEN 0,4% 54.595 1.708 0,4% 60 59 73 70 R03AK SYMPATHICOMIMETICA MET ANDERE ASTMAMIDDELEN 0,4% 54.027 3.418 0,8% 33 31 74 71 N03AF CARBOXAMIDEDERIVATEN 0,4% 52.422 1.802 0,4% 59 58 75 73 A03FA PROPULSIVA 0,4% 51.784 805 0,2% 97 96 76 65 C01DA ORGANISCHE NITRATEN 0,3% 47.788 2.765 0,6% 41 34 77 75 C07AA BETA-RECEPTORBLOKKERENDE MIDDELEN, NIET-SELECTIEVE 0,3% 45.989 3.423 0,8% 32 32 78 80 A09AA ENZYMPREPARATEN 0,3% 43.812 687 0,2% 104 110 79 76 R03BC ANTI-ALLERGISCHE MIDDELEN, EXCL. CORTICOSTEROIDEN 0,3% 42.044 849 0,2% 94 89 80 95 N02AB FENYLPIPERIDINEDERIVATEN 0,3% 39.293 604 0,1% 107 118 81 79 L04AX OVERIGE IMMUNOSUPPRESSIVA 0,3% 38.760 679 0,1% 105 105 82 83 C03DA ALDOSTERONANTAGONISTEN 0,3% 37.670 1.460 0,3% 64 64 83 78 G01AF IMIDAZOLDERIVATEN 0,3% 37.523 1.314 0,3% 70 67 84 86 C01BC ANTI-ARITMICA (KLASSE IC) 0,3% 37.107 1.079 0,2% 81 81 85 84 H03AA SCHILDKLIERHORMONEN 0,3% 36.115 7.856 1,7 ...

année 2000 101.653.250,76 4,6% 102.301.852,38 4,7% 103.178.896,83 4,5% 106.924.597,43 4,1% 84.049.345,09 3,1% année 2001 222.020.492,17 10,1% 200.837.869,58 9,3% 208.476.465,56 9,1% 223.423.447,06 8,6% 211.891.293,09 7,9% année 2002 428.182.463,39 19,4% 400.615.034,66 18,5% 389.923.033,50 17,0% 433.220.402,40 16,6% 431.169.454,98 16,1% année 2003 261.017.432,94 11,8% 269.134.257,97 12,4% 283.197.072,28 12,3% 289.251.643,28 11,1% 265.702.381,48 9,9% année 2004 190.967.617,42 8,7% 212.673.306,49 9,8% 237.252.963,14 10,3% 276.876.788,72 10,6% 297.141.541,41 11,1% année 2005 28.447.212,43 1,3% 127.045.065,73 5,9% 164.057.732,51 7,1% 190.339.294,46 7,3% 191.410.965,71 7,1% année 2006 30.746.721,41 1,4% 92.764.705,85 4,0% 117.947.907,47 4,5% 122.339.662,93 4,6% année 2007 27.215.273,72 1,2% 127.519.458,84 4,9% 149.933.477,71 5,6% année 2008 46.662.199,15 1,8% 140.491.100,70 5,2% année 2009 78.946.897,44 2,9% TOTAL 2.206.159.935,74 100,0% 2.163.539.552,05 100,0% 2.295.550.665,61 100,0% 2.609.606.693,58 100,0% 2.684.317.428,25 100,0%
jaar 2000 101.653.250,76 4,6% 102.301.852,38 4,7% 103.178.896,83 4,5% 106.924.597,43 4,1% 84.049.345,09 3,1% jaar 2001 222.020.492,17 10,1% 200.837.869,58 9,3% 208.476.465,56 9,1% 223.423.447,06 8,6% 211.891.293,09 7,9% jaar 2002 428.182.463,39 19,4% 400.615.034,66 18,5% 389.923.033,50 17,0% 433.220.402,40 16,6% 431.169.454,98 16,1% jaar 2003 261.017.432,94 11,8% 269.134.257,97 12,4% 283.197.072,28 12,3% 289.251.643,28 11,1% 265.702.381,48 9,9% jaar 2004 190.967.617,42 8,7% 212.673.306,49 9,8% 237.252.963,14 10,3% 276.876.788,72 10,6% 297.141.541,41 11,1% jaar 2005 28.447.212,43 1,3% 127.045.065,73 5,9% 164.057.732,51 7,1% 190.339.294,46 7,3% 191.410.965,71 7,1% jaar 2006 30.746.721,41 1,4% 92.764.705,85 4,0% 117.947.907,47 4,5% 122.339.662,93 4,6% jaar 2007 27.215.273,72 1,2% 127.519.458,84 4,9% 149.933.477,71 5,6% jaar 2008 46.662.199,15 1,8% 140.491.100,70 5,2% jaar 2009 78.946.897,44 2,9% TOTAAL 2.206.159.935,74 100,0% 2.163.539.552,05 100,0% 2.295.550.665,61 100,0% 2.609.606.693,58 100,0% 2.684.317.428,25 100,0%

1 G03GA G03GA02 GONADOTROPHINE MENOPAUSALE HUMAINE 9.030 86,1% 1.097,2 G03GA06 FOLLITROPINE BETA 1.653 91,9% 49,3 G03GA05 FOLLITROPINE ALFA 448 92,5% 15,2 G03GA01 GONADOTROPHINE CHORIONIQUE 322 77,3% 1.204,1 2 G03AA G03AA09 DESOGESTREL ET ESTROGENES 3.223 38,3% 23.697,7 G03AA10 GESTODENE ET ESTROGENES 3.015 35,2% 16.329,7 G03AA07 LEVONORGESTREL ET ESTROGENES 692 27,8% 6.435,1 G03AA11 NORGESTIMATE ET ESTROGENES 685 34,7% 3.556,9 G03AA05 NORETHISTERONE ET ESTROGENES 113 41,5% 1.049,4 3 J02AC J02AC01 FLUCONAZOLE 2.539 15,0% 368,1 J02AC02 ITRACONAZOLE 741 7,1% 185,6 J02AC03 VORICONAZOLE 0 0,0% 0,0 4 L02BG L02BG03 ANASTROZOLE 1.799 18,7% 399,5 L02BG04 LETROZOLE 445 11,2% 100,6 L02BG06 EXEMESTANE 233 9,9% 52,0 L02BG01 AMINOGLUTHETIMIDE 0 0,6% 0,0 5 G03DA G03DA04 PROGESTERONE 2.389 64,3% 5.279,7 G03DA02 MEDROXYPROGESTERONE 19 23,1% 116,1 6 G03DB G03DB04 NOMEGESTROL 1.842 63,0% 2.152,2 G03DB01 DYDROGESTERONE 496 53,2% 1.159,0 G03DB03 MEDROGESTONE 1 20,7% 4,3 7 M05BA M05BA04 ACIDE ALENDRONIQUE 1.478 4,3% 1.271,6 M05BA07 ACIDE RISEDRONIQUE 561 5,3% 485,0 M05BA06 ACIDE IBANDRONIQUE 91 6,2% 7,7 M05BA02 ACIDE CLODRONIQUE 10 1,6% 1,3 M05BA01 ACIDE ETIDRONIQUE 1 3,0% 0,6 8 L02AE L02AE01 BUSERELINE 824 86,7% 181,7 L02AE03 GOSERELINE 521 4,7% 100,9 L02AE04 TRIPTORELINE 210 2,3% 40,1 L02AE02 LEUPRORELINE 0 0,0% 0,1 9 G03CA G03CA03 ESTRADIOL 1.052 42,8% 6.336,5 G03CA04 ESTRIOL 204 12,0% 823,0 G03CA57 ESTROGENES CONJUGUES 2 19,8% 20,9 10 L02BA L02BA01 TAMOXIFENE 1.212 23,5% 1.846,0 L02BA02 TOREMIFENE 5 30,0% 6,0 11 G03AB G03AB06 GESTODENE ET ESTROGENES 482 36,3% 2.252,6 G03AB03 LEVONORGESTREL ET ESTROGENES 387 29,9% 2.209,7 G03AB04 NORETHISTERONE ET ESTROGENES 42 33,9% 237,8 G03AB05 DESOGESTREL ET ESTROGENES 3 38,2% 20,0 12 G03HB G03HB01 CYPROTERONE ET ESTROGENES 826 36,9% 4.581,9 13 G01AF G01AF04 MICONAZOLE 446 23,7% 708,5 G01AF15 BUTOCONAZOLE 142 61,3% 72,9 G01AF02 CLOTRIMAZOLE 61 34,1% 50,9 G01AF01 METRONIDAZOLE 50 69,4% 175,4 G01AF05 ECONAZOLE 17 37,4% 14,2 14 B01AB B01AB06 NADROPA ...
1 G03GA G03GA02 MENOPAUZEGONADOTROPINE (HUMAAN) 9.030 86,1% 1.097,2 G03GA06 FOLLITROPINE BETA 1.653 91,9% 49,3 G03GA05 FOLLITROPINE ALFA 448 92,5% 15,2 G03GA01 CHORIONGONADOTROPINE 322 77,3% 1.204,1 2 G03AA G03AA09 DESOGESTREL MET OESTROGENEN 3.223 38,3% 23.697,7 G03AA10 GESTODEEN MET OESTROGENEN 3.015 35,2% 16.329,7 G03AA07 LEVONORGESTREL MET OESTROGENEN 692 27,8% 6.435,1 G03AA11 NORGESTIMAAT MET OESTROGENEN 685 34,7% 3.556,9 G03AA05 NORETHISTERON MET OESTROGENEN 113 41,5% 1.049,4 3 J02AC J02AC01 FLUCONAZOL 2.539 15,0% 368,1 J02AC02 ITRACONAZOL 741 7,1% 185,6 J02AC03 VORICONAZOL 0 0,0% 0,0 4 L02BG L02BG03 ANASTROZOL 1.799 18,7% 399,5 L02BG04 LETROZOL 445 11,2% 100,6 L02BG06 EXEMESTAAN 233 9,9% 52,0 L02BG01 AMINOGLUTETHIMIDE 0 0,6% 0,0 5 G03DA G03DA04 PROGESTERON 2.389 64,3% 5.279,7 G03DA02 MEDROXYPROGESTERON 19 23,1% 116,1 6 G03DB G03DB04 NOMEGESTROL 1.842 63,0% 2.152,2 G03DB01 DYDROGESTERON 496 53,2% 1.159,0 G03DB03 MEDROGESTON 1 20,7% 4,3 7 M05BA M05BA04 ALENDRONINEZUUR 1.478 4,3% 1.271,6 M05BA07 RISEDRONINEZUUR 561 5,3% 485,0 M05BA06 IBANDRONINEZUUR 91 6,2% 7,7 M05BA02 CLODRONINEZUUR 10 1,6% 1,3 M05BA01 ETIDRONINEZUUR 1 3,0% 0,6 8 L02AE L02AE01 BUSERELINE 824 86,7% 181,7 L02AE03 GOSERELINE 521 4,7% 100,9 L02AE04 TRIPTORELINE 210 2,3% 40,1 L02AE02 LEUPRORELINE 0 0,0% 0,1 9 G03CA G03CA03 ESTRADIOL 1.052 42,8% 6.336,5 G03CA04 ESTRIOL 204 12,0% 823,0 G03CA57 OESTROGENEN, GECONJUGEERD 2 19,8% 20,9 10 L02BA L02BA01 TAMOXIFEN 1.212 23,5% 1.846,0 L02BA02 TOREMIFEN 5 30,0% 6,0 11 G03AB G03AB06 GESTODEEN MET OESTROGENEN 482 36,3% 2.252,6 G03AB03 LEVONORGESTREL MET OESTROGENEN 387 29,9% 2.209,7 G03AB04 NORETHISTERON MET OESTROGENEN 42 33,9% 237,8 G03AB05 DESOGESTREL MET OESTROGENEN 3 38,2% 20,0 12 G03HB G03HB01 CYPROTERON MET OESTROGENEN 826 36,9% 4.581,9 13 G01AF G01AF04 MICONAZOL 446 23,7% 708,5 G01AF15 BUTOCONAZOL 142 61,3% 72,9 G01AF02 CLOTRIMAZOL 61 34,1% 50,9 G01AF01 METRONIDAZOL 50 69,4% 175,4 G01AF05 ECONAZOL 17 37,4% 14,2 14 B01AB B01AB06 NADROPARINE 356 1,4% 143, ...

1 C10AA05 ATORVASTATINE 80.686.584 146.899.233 251.820 2 2% 1998 2 B01AC04 CLOPIDOGREL 47.609.277 30.244.418 113.011 27 27% 2001 3 R03AK06 SALMETEROL AVEC UN CORTICOSTEROIDE 44.577.901 31.013.408 207.593 25 6% 2001 4 C10AA01 SIMVASTATINE 43.269.689 219.557.941 466.220 1 -1% 1990 5 A02BC01 OMEPRAZOLE 42.683.976 86.292.134 500.152 5 -4% 1980 6 A02BC02 PANTOPRAZOLE 34.695.179 23.683.199 176.992 44 14% 1980 7 B02BD02 FACTEUR VIII DE COAGULATION 33.984.254 70.418 234 519 15% 1980 8 L04AA11 ETANERCEPT 33.566.248 834.160 3.479 309 - 2002 9 N06AX16 VENLAFAXINE 32.739.744 27.191.385 127.232 35 11% 1997 10 C01DX12 MOLSIDOMINE 31.933.364 94.529.527 140.269 4 3% 1981 11 L03AB07 INTERFERON BETA-1A 29.818.130 1.791.998 2.982 230 16% 1998 12 M05BA04 ACIDE ALENDRONIQUE 29.115.811 29.103.305 109.318 30 13% 1998 13 N06AB10 ESCITALOPRAM 26.718.947 30.546.355 193.557 26 - 2003 14 N05AX08 RISPERIDONE 24.797.677 6.333.984 78.707 134 14% 1996 15 N05AH03 OLANZAPINE 24.021.020 6.090.065 41.349 140 13% 1999 16 R03AK07 FORMOTEROL AVEC UN CORTICOSTEROIDE 23.918.061 13.252.575 135.935 79 - 2002 17 C09AA04 PERINDOPRIL 22.935.935 47.969.318 179.030 15 17% 1990 18 J01CR02 AMOXICILLINE ET INHIBITEURS D'ENZYME 22.185.210 26.047.626 1.302.957 37 -6% 1986 19 C10AA07 ROSUVASTATINE 22.177.111 33.949.820 112.163 21 - 2003 20 C08CA01 AMLODIPINE 22.161.921 96.941.593 278.312 3 -14% 1990 21 V03AN01 OXYGENE 21.353.300 928.016 23.194 298 37% 1980 22 B01AB06 NADROPARINE 21.275.316 10.817.218 167.211 94 5% 1988 23 L04AA17 ADALIMUMAB 20.267.709 482.798 1.945 372 - 2004 24 C07AB07 BISOPROLOL 19.263.830 75.365.644 484.015 7 -1% 1988 25 R03BB04 BROMURE DE TIOTROPIUM 18.988.146 13.405.282 78.063 75 - 2004 TOTAL TOP 25 774.744.341 1.053.341.421 - - - -
1 C10AA05 ATORVASTATINE 80.686.584 146.899.233 251.820 2 2% 1998 2 B01AC04 CLOPIDOGREL 47.609.277 30.244.418 113.011 27 27% 2001 3 R03AK06 SALMETEROL MET EEN CORTICOSTEROID 44.577.901 31.013.408 207.593 25 6% 2001 4 C10AA01 SIMVASTATINE 43.269.689 219.557.941 466.220 1 -1% 1990 5 A02BC01 OMEPRAZOL 42.683.976 86.292.134 500.152 5 -4% 1980 6 A02BC02 PANTOPRAZOL 34.695.179 23.683.199 176.992 44 14% 1980 7 B02BD02 BLOEDSTOLLINGSFACTOR VIII (ANTIHEMOFILIEFACTOR A) 33.984.254 70.418 234 519 15% 1980 8 L04AA11 ETANERCEPT 33.566.248 834.160 3.479 309 - 2002 9 N06AX16 VENLAFAXINE 32.739.744 27.191.385 127.232 35 11% 1997 10 C01DX12 MOLSIDOMINE 31.933.364 94.529.527 140.269 4 3% 1981 11 L03AB07 INTERFERON BETA-1A 29.818.130 1.791.998 2.982 230 16% 1998 12 M05BA04 ALENDRONINEZUUR 29.115.811 29.103.305 109.318 30 13% 1998 13 N06AB10 ESCITALOPRAM 26.718.947 30.546.355 193.557 26 - 2003 14 N05AX08 RISPERIDON 24.797.677 6.333.984 78.707 134 14% 1996 15 N05AH03 OLANZAPINE 24.021.020 6.090.065 41.349 140 13% 1999 16 R03AK07 FORMOTEROL MET EEN CORTICOSTEROID 23.918.061 13.252.575 135.935 79 - 2002 17 C09AA04 PERINDOPRIL 22.935.935 47.969.318 179.030 15 17% 1990 18 J01CR02 AMOXICILLINE MET ENZYMREMMER 22.185.210 26.047.626 1.302.957 37 -6% 1986 19 C10AA07 ROSUVASTATINE 22.177.111 33.949.820 112.163 21 - 2003 20 C08CA01 AMLODIPINE 22.161.921 96.941.593 278.312 3 -14% 1990 21 V03AN01 ZUURSTOF 21.353.300 928.016 23.194 298 37% 1980 22 B01AB06 NADROPARINE 21.275.316 10.817.218 167.211 94 5% 1988 23 L04AA17 ADALIMUMAB 20.267.709 482.798 1.945 372 - 2004 24 C07AB07 BISOPROLOL 19.263.830 75.365.644 484.015 7 -1% 1988 25 R03BB04 TIOTROPIUM BROMIDE 18.988.146 13.405.282 78.063 75 - 2004 TOTAAL TOP 25 774.744.341 1.053.341.421 - - - -

DE LA DECARBOXYLASE ET DE LA COMT 0 0 0 0 392.491 2.875.489 3.867.104 N04BB01 AMANTADINE 39.603 41.705 45.979 48.640 48.240 46.207 46.524 N04BC01 BROMOCRIPTINE 1.743.567 1.430.796 1.103.419 793.889 600.713 457.563 365.866 N04BC02 PERGOLIDE 3.698.153 4.402.924 4.750.205 4.608.249 4.390.196 3.073.092 2.183.786 N04BC04 ROPINIROLE 514.818 998.174 1.299.677 1.857.600 2.491.843 3.183.513 3.556.828 N04BC05 PRAMIPEXOLE 1.989 442.008 1.372.432 2.108.926 2.616.501 3.430.619 3.914.049 N04BD01 SELEGILINE 1.735.757 1.672.997 1.528.522 1.439.033 1.429.377 1.341.368 1.232.290 N04BD02 RASAGILINE 0 0 0 0 0 0 40.692 N04BX01 TOLCAPONE 0 0 0 0 0 0 8.519 N04BX02 ENTACAPONE 218.632 1.259.895 2.051.947 2.670.294 3.152.974 2.187.780 1.883.580 TOTAL 13.823.413 16.204.300 18.163.430 19.631.919 21.109.347 22.217.252 22.594.669
0 0 0 0 392.491 2.875.489 3.867.104 N04BB01 AMANTADINE 39.603 41.705 45.979 48.640 48.240 46.207 46.524 N04BC01 BROMOCRIPTINE 1.743.567 1.430.796 1.103.419 793.889 600.713 457.563 365.866 N04BC02 PERGOLIDE 3.698.153 4.402.924 4.750.205 4.608.249 4.390.196 3.073.092 2.183.786 N04BC04 ROPINIROL 514.818 998.174 1.299.677 1.857.600 2.491.843 3.183.513 3.556.828 N04BC05 PRAMIPEXOL 1.989 442.008 1.372.432 2.108.926 2.616.501 3.430.619 3.914.049 N04BD01 SELEGILINE 1.735.757 1.672.997 1.528.522 1.439.033 1.429.377 1.341.368 1.232.290 N04BD02 RASAGILINE 0 0 0 0 0 0 40.692 N04BX01 TOLCAPON 0 0 0 0 0 0 8.519 N04BX02 ENTACAPON 218.632 1.259.895 2.051.947 2.670.294 3.152.974 2.187.780 1.883.580 TOTAAL 13.823.413 16.204.300 18.163.430 19.631.919 21.109.347 22.217.252 22.594.669

Dossiers transmis au SCA 147 171 212 170 239 236 243 231 252 Dossiers transmis au Service d es 12 3 13 11 8 7 2 81 72 indemnités Sanctions administratives SCA 90 145 109 201 149 189 223 154 195 Indemnisation suspendue 4.424 6.995 4.990 11.188 7.890 1.823 13.524 1.768 14.947 Somme globale en FB 36.612.631,00 77.627.026 71.128.322 71.865.522 50.870.003 8.033.354 78.989.289 52.689.952,32 62.244.430,60 Somme globale en euros 907.603,41 1.924.323,71 1.763.225,05 1.781.499,76 1.261.034,43 1.983.975,27 1.958.093,33 1.306.149,81 1.542.999,13 Bénéficiaires 115 165 202 180 195 212 256 191 206
Dossiers verzonden naar 147 171 212 170 239 236 243 231 252 DAC Dossiers verzonden naar 12 3 13 11 8 7 2 81 72 Dienst voor uitkeringen Administratieve sancties 90 145 109 201 149 189 223 154 195 DAC Ingehouden uitkeringen 4.424 6.995 4.990 11.188 7.890 1.823 13.524 1.768 14.947 Globale som in BEF 36.612.631 ,00 77.627.026 71.128.322 71.865.522 50.870.003 8.033.354 78.989.289 52.689.952,32 62.244.430,60 Globale som in EUR 907.603,41 1.924.323,71 1.763.225,05 1.781.499,76 1.261.034,43 1.983.975,27 1.958.093,33 1.306.149,81 1.542.999,13 Rechthebbenden 115 165 202 180 195 212 256 191 206